IP Library Granted Patent US 8,114,647
Granted Patent B2
US 8,114,647 · App. 11/975,605 · Granted Feb 14, 2012

Blood brain barrier device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,647
App. No.
11/975,605
Granted
Feb 14, 2012
Kind
B2
Abstract

Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects.

Claims (38)

1. A method for delivering one or more biologically active molecules to a subject, comprising:

providing one or more biologically active molecules;

providing one or more devices with a semi-permeable component including a confluent tissue coating of blood brain barrier capillary endothelial cells;

at least one structural component that is at least partially composed of porous bone that is in contact with and supports the semi-permeable component;

the semi-permeable component substantially surrounds the at least one structural component; and

an internal cavity that is substantially surrounded by the semi-permeable component and at least a portion of the porous bone;

the one or more biologically active molecules included in the pores and/or the cavity of the one or more devices;

and implanting in the subject one or more of the devices containing the biologically active molecules;

wherein at least one characteristic of the blood brain barrier capillary endothelial cells is different from the at least one corresponding characteristic of peripheral capillary endothelial cells.

2. The method of claim 1 , further comprising: providing the one or more biologically active molecules to the internal cavity.

3. The method of claim 2 , wherein providing the one or more biologically active molecules to the internal cavity comprises: providing the one or more biologically active molecules to the internal cavity through one or more closable openings; and closing the one or more closable openings.

4. The method of claim 2 , wherein providing the one or more biologically active molecules to the internal cavity comprises:

providing one or more living cells or tissues to the internal cavity, wherein the one or more living cells or tissues release the one or more biologically active molecules.

5. the method of claim 4 , wherein the one or more living cells or tissues are engineered to release the one or more biologically active molecules.

6. The method of claim 1 , wherein the semi-permeable component substantially surrounds an interior of the internal cavity of the one or more devices.

7. The method of claim 1 , wherein the semi-permeable component substantially surrounds an exterior of the one or more devices including the internal cavity.

8. A method for delivering one or more biologically active molecules to a subject, comprising:

providing one or more devices with a semi-permeable component including: a confluent tissue coating of a blood brain barrier capillary endothelial cells;

at least one structural component that is at least partially composed of porous bone that is in contact with and supports the semi-permeable component;

the semi-permeable component substantially surrounds the at least one structural component;

wherein the one or more devices form an internal cavity that is substantially surrounded by the semi-permeable component and at least a portion of the porous bone:

implanting in the subject one or more of the devices; providing the one or more biologically active molecules into the internal cavity following implantation of the one or more devices into the subject;

wherein at least one characteristic of the blood brain barrier capillary endothelial cells is different from the at least one corresponding characteristic of peripheral capillary endothelial cells.

9. A method of assembling a device for delivering one or more biologically active molecules to a subject, comprising:

providing one or more biologically active molecules; and providing one or more devices with a semi-permeable component including a confluent tissue coating of blood brain barrier capillary endothelial cells;

at least one structural component that is at least partially composed of porous bone that is in contact with and supports the semi-permeable component;

the semi-permeable component substantially surrounds the at least one structural component;

an internal cavity that is substantially surrounded by the semi-permeable component and at least a portion of the porous bone; and

the one or more biologically active molecules included in the pores and/or the cavity of the one or more devices;

wherein at least one characteristic of the one or more characteristics of the blood brain barrier capillary endothelial cells is different from at least one corresponding characteristic of peripheral capillary endothelial cells.

10. The method of claim 9 , further comprising: providing the one or more biologically active molecules to the internal cavity.

11. The method of claim 10 , further comprising:

identifying one or more living cells or tissues to release the one or more biologically active molecules; and providing the one or more living cells or tissues to the internal cavity.

12. The method of claim 11 , wherein the one or more living cells or tissues are engineered to release the one or more biologically active molecules.

13. The method of claim 10 , wherein providing the one or more biologically active molecules to the internal cavity comprises:

providing one or more living cells or tissues to the internal cavity, wherein the one or more living cells or tissues release the one or more biologically active molecules.

14. The method of claim 9 , wherein the one or more devices include one or more closable openings.

15. The method of claim 14 , further comprising: closing the one or more closable openings.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2012
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 027470/0640 →